Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 3/2018

17.07.2018 | editorial

Cure in metastatic disease

verfasst von: Dr. Hannes Kaufmann

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 3/2018

Einloggen, um Zugang zu erhalten

Excerpt

One of the principles in oncology over decades was that patients diagnosed with metastatic cancer were unlikely to be cured of their disease by any means. At best, treatment with classical chemotherapy ended in extended progression-free or overall survival. Complete remissions from systemic standard chemotherapy are uncommon, and only a fraction of complete responders remain progression free for a prolonged period in most malignant diseases. …
Literatur
1.
Zurück zum Zitat Daneshmand S, Albers P, Fosså SD, et al. Contemporary management of postchemotherapy testis cancer. Eur Urol. 2012;62(5):867–76.CrossRefPubMed Daneshmand S, Albers P, Fosså SD, et al. Contemporary management of postchemotherapy testis cancer. Eur Urol. 2012;62(5):867–76.CrossRefPubMed
4.
Zurück zum Zitat Corbin KS, Hellman S, Weichselbaum RR. Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol. 2013;31:1384–90.CrossRefPubMed Corbin KS, Hellman S, Weichselbaum RR. Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. J Clin Oncol. 2013;31:1384–90.CrossRefPubMed
Metadaten
Titel
Cure in metastatic disease
verfasst von
Dr. Hannes Kaufmann
Publikationsdatum
17.07.2018
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 3/2018
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-018-0423-z

Weitere Artikel der Ausgabe 3/2018

memo - Magazine of European Medical Oncology 3/2018 Zur Ausgabe